A **bipartisan group** of lawmakers is urging the **FTC** to approve the release of an **interim report** on pharmacy benefit managers (**PBMs**).
Lawmakers raised concerns that **PBMs** have evolved into enormous entities that control the entire **drug coverage** and delivery process.
The **FTC's initial report** in 2022 highlighted how dominant **PBMs** use their market power to profit at patients' expense, especially affecting **independent pharmacists**.
Proposed legislation would prevent the **joint ownership** of PBMs and pharmacies to avoid conflicts of interest, citing the **FTC's findings** as foundational.
A **virtual commission meeting** is scheduled for **January 14**, where the public will have the chance to address the commission regarding these issues.